Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

Make the Trend Your Friend With This SPY Trade: Market Recon

Don't try to fight the market trend, work with it -- but keep an eye to the news and be ready to act.

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Beware the Ides of March -- Maybe Shakespeare Was an Investor?

Between options expiry and seasonality, March is a tricky month to navigate.

Don't Blindly Accept the 'Sell the News' Rhetoric

The bears will be out in full force -- but this market is all about second- and third-level thinking, so make sure you question simplistic arguments.

Will the Greater Bay Area Plan Produce China's Silicon Valley?

Cement stocks will be big beneficiaries of the Chinese administration's infrastructure growth plans.

Copper Is Stuck Between a Rock and a Hard Place

Doctor Copper is still a harbinger of global economic health -- keep a close eye on copper prices as the trade war marches on.

Investors Fear Missing Out as Momentum Takes S&P 500 higher

Equity markets can continue to move up and regain lost performance -- valuations are supportive and company's earnings are not as bad as feared.

Watch this Japanese Stock Rise as China Heads Down the Slopes

Nippon Parking Development Co. is still a force in parking, but it's also an operator of prime ski resorts in Japan that have become a magnet for skiers throughout Asia.